Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
Project Also Seeks to Develop Better Tools to Test Truth of Seafood Labels
SANTA CLARA, Calif., March 19, 2012
More Headlines
- Ampace C5 Transforms Commercial and Industrial Energy Storage
- Trina Storage and Pacific Green sign Letter of Intent of 1500 MWh energy storage system at WFES
- Residential 30KW Off Grid Solar panel System 30000W energy storage solar system complete set
- Soltec Supplies 367 MW of its SFOne Tracker in Lorca (Murcia) to X-ELIO
- Comau's Digital Technologies to Improve Battery Cell Production Reaching up to Zero Defects for The Battwin Project
Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration to develop new tools to detect and analyze pathogens in food.
The joint R&D effort will also seek to improve DNA-based tools for confirming that seafood is correctly labeled.
The goal of the first part of the project is to develop a novel assay panel to identify subtypes of salmonella in food. When outbreaks occur, knowing the subtype can help officials quickly identify the source of the pathogen and hopefully limit the number of victims. The research will focus on using mass spectrometry-based genotyping to quickly identify salmonella subtypes.
"This effort on the part of Agilent is of extraordinary importance to the FDA," said Eric W. Brown, Ph.D, director, Division of Microbiology, FDA. "We expect this collaboration will be an important step in the development of new and specific tools for tracking bacterial pathogens in foods."
The second part of the agreement - to be carried out in collaboration with both the FDA and the Campden BRI laboratory in the United Kingdom - aims to update Agilent's lab-on-a-chip method of DNA analysis to identify fish species. Agilent's analytical technique can identify species even after the fish has been processed, which generally removes identifying features such as the head, tail and skin. The technology is based on the Agilent Bioanalyzer, using restriction fragment length polymorphism. The goal is to make this technology fast, inexpensive and simple enough that many kinds of laboratories can use it on a routine basis. This type of test could detect such things as intentional mislabeling to avoid tariffs and import restrictions or economic fraud where a less expensive species of fish is sold as a more costly species.
"We're very pleased to be collaborating with the FDA, because this work holds tremendous potential for solving some very challenging threats to the safety and integrity of the food supply," said Paul Zavitsanos, Agilent Global Food Safety manager. "There's real value in applying biological analysis techniques to food safety, and this collaboration advances our shared vision."
For more information about Agilent's food testing tools, visit www.agilent.com/chem/foodsafety.
Featured Product
Raptor Maps - The integrated operating system for end-to-end solar management
Operate autonomous drones and other robotics technology on your solar farms with Raptor Maps' robotics operations platform. Our end-to-end solution allows you to build and schedule data collection missions, to analyze collected data through our analytics engine, and to address identified issues through our remediation intelligence suite. From construction monitoring to substation inspections to SCADA-alert generation missions, Raptor Robotics gives your team unparalleled insights into the health and status of your project. Improve the safety, efficiency, and scale of your operations with Raptor Robotics.
